Absci Corporation (ABSI) vs AnaptysBio, Inc. (ANAB)
- Absci Corporation ABSI 8.25 −7.09%
- AnaptysBio, Inc. ANAB 46.61 −4.31%
Absci Corporation and AnaptysBio, Inc. are both Biotechnology companies. Absci Corporation and AnaptysBio, Inc. are of similar size ($1.5B and $1.5B). AnaptysBio, Inc. grew revenue faster over the last twelve months: 107.7% against −62.3%. AnaptysBio, Inc. has the higher net margin (−11.5% vs −7,756.4%) and the higher return on invested capital (0.00% vs −174.7%). Across the 17 metrics below, AnaptysBio, Inc. leads on 14 and Absci Corporation on 3.
Valuation
Profitability
| Metric | ABSI | ANAB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (8,084.50%) | 17.56% | 0.00% |
| Net margin | (7,756.37%) | (11.53%) | 0.00% |
| Free cash flow margin | (6,969.83%) | 1.90% | 0.00% |
| Return on equity | (57.72%) | (114.55%) | (56.36%) |
| Return on assets | (50.57%) | (7.13%) | (48.04%) |
| Return on invested capital | (174.74%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack